drugset / Trial / NCT00574223
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to test the efficacy of the combination treatment AllQbG10 in patients with perennial allergic rhinoconjunctivitis due to house dust mite allergy in a double-blind placebo-controlled setting
Timeline
- Start
- 2007-11
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CYT003-QbG10 | Vaccine | — | Subcutaneous |
| Subject | House dust mite allergen extract | Unknown | — | Subcutaneous |